Online survey
BehavioralOnline survey to capture indirect and out of pocket costs of Huntington's Disease in HDGECs and companions
NCT Number: NCT03628235
Huntington's disease (HD) is a rare, inherited and progressive neurodegenerative disorder for which hallmark symptoms include movement disorders, loss of cognitive faculties and psychiatric disturbances. With the progression of the disease, patients require increasing level of medical care, caregiver support, and long-term care, which lead to substantial burden of illness. Very little data are available on the direct or indirect costs for HD. The direct medical costs of HD in the US have been summarized from retrospective commercial and Medicaid claims data analysis. The indirect and out-of-pocket costs of HD in the US have not been quantified. This study will help to bridge these gaps.
This study is a single-assessment, cross-sectional online survey administered to Huntington disease gene expansion carriers (HDGECs) and companions of HDGECs by HD stage to understand the indirect and out-of-pocket costs of Huntington's disease in the US.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
The survey collects the following data from each HDGEC and companion:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for HDGECs:
Stage classification of HDGECs:
Exclusion criteria
for HDGECs:
HDGECs will be excluded from the study if they have significant cognitive or any other impairment sufficient to interfere with study associated tasks as judged by the Site PI or Site PI's designee (exceptions will be made if a companion/LAR completes the survey on their behalf).
Inclusion criteria
for companions:
Exclusion criteria
for companions:
Companions will be excluded from the study if they are identified as paid or salaried caregivers; however, the HDGECs for whom they care may still be included in the study.
Online survey to capture indirect and out of pocket costs of Huntington's Disease in HDGECs and companions
Time frame: 12 months
Productivity loss is measured by annual lost wages and it is collected in the survey's employment questionnaires and WPAI
Time frame: 12 months
The indirect costs associated with the total annual out-of-pocket expenses.
Time frame: 12 months
The total informal care time received during a typical week
Time frame: 12 months
The indirect costs associated with the annual opportunity costs of companion
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
For HDGECs and Companions: Understand how the traditional disease staging system, based on the TFC score, relates to a staging system based on resource utilization questionnaire and comorbid conditions developed in Divino et al. (2013)
CHDI Foundation, Inc.
Other
Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07601516
Basal Ganglia Diseases, Brain Diseases
Beijing, China
View Trial DetailsNCT01860339
Basal Ganglia Diseases, Brain Diseases
Sacramento, California, United States
View Trial DetailsNCT05107128
Basal Ganglia Diseases, Brain Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT03664804
Basal Ganglia Diseases, Brain Diseases
Englewood, Colorado, United States
View Trial Details